Arcus Biosciences (RCUS)

Arcus Biosciences (RCUS-N) currently faces financial challenges, as indicated by experts who note that the company is losing money. This raises concerns regarding its long-term viability and performance. Experts recommend considering this stock only as a speculative investment, particularly for those who do not already hold other speculative stocks in their portfolios. The suggestion to limit the holding of speculative stocks to one highlights the risk associated with investing in such companies. Overall, while there may be potential for growth, investors should proceed with caution and conduct thorough research before making any investment decisions.